Levocabastine Hydrochloride

盐酸左卡巴斯汀

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameLevocabastine Hydrochloride
Drug Alias Name盐酸左卡巴司丁levocabastinalevocabastinum盐酸左卡巴斯丁盐酸左旋卡巴斯汀 +[12] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H1 receptor antagonists
TargetsHistamine H1 receptor
Therapy Area/IndicationsConjunctivitis, AllergicRhinitis, Allergic, SeasonalRhinitis, Allergic, Perennial +[4] 
Global Approved IndicationsConjunctivitis, AllergicRhinitis, Allergic, PerennialRhinitis, Allergic
Approved Indications in ChinaRhinitis, Allergic
Original Approved Country/TerritoryUnited States
Original Approved Date1993/11/10
Country/TerritoryCanadaUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesJanssen Pharmaceutical Nv
Inactive CompaniesGlaxosmithkline PlcNovartis Pharma Ag
Active IndicationsRhinitis, Allergic
Inactive IndicationsConjunctivitis, AllergicRhinitis, Allergic, SeasonalRhinitis, Allergic, Perennial

Other Information

ATC CodeR01AC02S01GX02
Related LinksWikipediaDrugBankKEGG